3 "inflammatory bowel diseases" clinical trials found.
-
GS-US-457-6411: A Phase 2 Double-Blinded Randomized Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of GS-5290 in Participants with Moderately to Severely Active Ulcerative Colitis
The goal of this study is to learn if investigational drug tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with ...Phase
Interventional
-
C5041018 A PHASE 2 OPEN LABEL SINGLE ARM STUDY TO EVALUATE THE EFFICACY PHARMACOKINETICS AND SAFETY OF ETRASIMOD IN PEDIATRIC PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
The purpose of this study is to assess the effects of the study drug, etrasimod, for treating pediatric ulcerative colitis (UC) participants. Participants will take ...Phase
Interventional
-
A Phase 2 Randomized Double-blind Placebo-controlled Parallel Study Evaluating the Safety and Efficacy of LB-P8 in Patients with Primary Sclerosing Cholangitis (PSC)
This main purpose of this placebo-controlled study to assess the safety and efficacy of LB-P8 in adult patients with Primary Sclerosing Cholangitis (PSC). The study ...Phase
Interventional
